Back to Results
First PageMeta Content
Financial ratio / Balance sheet / Business / Regulus Therapeutics / Rosetta Genomics / MicroRNA / Financial statements


Microsoft Word - Earnings release - final for release.doc
Add to Reading List

Document Date: 2013-06-20 11:12:45


Open Document

File Size: 196,32 KB

Share Result on Facebook

City

Rehovot / /

Company

NYU Medical Center / Proprietary MicroRNA Platform Technologies / Ernst & Young Global / Marketable Securities / microRNAs / Short-term Bank Deposit / Rosetta Genomics Ltd. / Isis Pharmaceuticals Inc. / /

Country

United States / Israel / /

Currency

USD / /

/

Event

Earnings Announcement / Conference Call / Business Partnership / M&A / /

Facility

Columbia University Medical Center / /

Holiday

D Day / /

IndustryTerm

diagnostic and therapeutic products / registered public accounting / biotechnology / diagnostic product / bank deposits / short-term bank deposits / /

MedicalCondition

ovarian cancer / non-squamous lung cancers / melanoma / mesothelioma / human diseases / adenocarcinoma / cancers / cancer / lung cancer / liver cancer / diseases / infectious diseases / non-squamous lung cancer / /

OperatingSystem

Isis / /

Organization

American Association of Cancer Research / Audit Committee / Columbia University Medical Center / Cambridge Healthcare Institute / NYU / /

Person

Amir Avniel / Alan Zachary / Juliane Snowden / /

/

Position

General and Administrative Expenses General / leader / President and CEO / Annual General / leader in the development / /

PublishedMedium

Cancer Research / /

Technology

diagnostic tests / biotechnology / /

URL

www.rosettagenomics.com / /

SocialTag